Clinical Trials
4 trialsNCT04375150 2024-09-19
Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC
Pfizer
Completed
NCT03890731 2024-04-02
A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed
Bayer
Phase 2 Completed
NCT05476562 2022-11-08
Study Conducted Among Patients With CML
Novartis
Completed
NCT01098500 2017-05-30
Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs
GlaxoSmithKline
Completed